Back to Report Store Home

Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need

  • Published: Jan-2013
  • Report Code: GBIHC293MR
  • Report Format: pdf

Description

List of Tables

Table 1: Probability of HbSS Genotype by Region 8

Table 2: Prevalence of a- and ß-Thalassemia (Hemoglobin H and ß-Thalassemia Intermedia and Major only) 14

Table 3: Global Distribution of Hereditary Angioedema, 2012 17

Table 4: Sickle Cell Anemia, Total Market, CAGR of Average Annual Cost of Therapy 23

Table 5: Thalassemia, Total Market, CAGR of Average Annual Cost of Therapy 31

Table 6: Hereditary Angioedema, Total Market, CAGR of Average Annual Cost of Therapy 40

Table 7: Sickle Cell Anemia: Research and Development Pipeline 49

Table 8: Thalassemia: Research and Development Pipeline 54

Table 9: Hereditary Angioedema: Research and Development Pipeline 58

Table 10: Mechanism of action abbreviations: 64

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards